Clinical Research in Cardiology·Oct 31Sacubitril/valsartan and the risk of incident dementia in heart failure: a nationwide propensity-matched cohort studyCohort study of 13,578 peopleSacubitril + valsartanPaper
Drugs & Aging·Jul 15Guideline-Directed Medical Therapies for Heart Failure with a Reduced Ejection Fraction in Older Adults: A Narrative Review on Efficacy, Safety and TimelinessReviewHeart failure with reduced ejection fractionPaper
Cardiology·Apr 12Do Elderly Patients with Heart Failure and Reduced Ejection Fraction Benefit from Pharmacological Strategies for Prevention of Arrhythmic Events?ReviewCardiac arrhythmiaPaper
Internal and Emergency Medicine·Dec 9Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysisStudy of 61 peopleSacubitril + valsartanPaper
Journal of the American College of Cardiology·Sep 2Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection FractionRandomized trial in 4,796 peopleSacubitril + valsartanPaper
Drugs & Aging·Jun 28The Prevalence of Adverse Drug Reactions and Adverse Drug Events from Heart Failure Medications in Frail Older Adults: A Systematic ReviewSystematic review of studies in peopleHeart failurePaper
Experimental Gerontology·May 23Valsartan and sacubitril combination treatment enhances collagen production in older adult human skin cellsExperiments in human cellsValsartanPaper
Annales de Cardiologie et D'angeiologie·Jul 19Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidanceReviewHeart failurePaper
Mechanisms of Ageing and Development·Sep 29Neprilysin expression and functions in development, ageing and diseaseReviewMechanismsPaper
Kardiologiia·Jun 10Modification of the of the cardiometabolic profile using combined therapy of the angiotensin receptor-neprilysin inhibitor and empagliflozin in comorbid patients with Chronic Heart Failure and type 2 Diabetes MellitusCase reportSGLT2 inhibitorsPaper
American Journal of Hypertension·Oct 11Efficacy and Safety of Sacubitril/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (≥65 Years) With Systolic HypertensionRandomized trial in 588 peopleSacubitril + valsartanPaper
Hypertension·Jan 18Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER StudyRandomized trial in 454 peopleSacubitril + valsartanPaper